The Myeloma Institute Social Work Department will host a Patient Support Seminar entitled “Handling the Holidays – a gift of healthy tips” on Thursday, December 3 from 5:30 – 7:00 PM. The seminar will be held in the Betsy Blass Boardroom on the 10th floor of the Cancer Institute and refreshments will be provided.
Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for treating multiple myeloma. Read more here: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm472875.htm